These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

651 related items for PubMed ID: 19721208

  • 1. [Therapeutic considerations on secondary osteoporosis caused by diabetes mellitus].
    Azuma K.
    Clin Calcium; 2009 Sep; 19(9):1345-52. PubMed ID: 19721208
    [Abstract] [Full Text] [Related]

  • 2. [Anabolic treatment for osteoporosis: PTH treatment].
    Kaji H, Sugimoto T.
    Clin Calcium; 2006 Sep; 16(9):1480-85. PubMed ID: 16951472
    [Abstract] [Full Text] [Related]

  • 3. [Absolute risk for fracture and WHO guideline. Treatment of patients with secondary osteoporosis].
    Yamauchi M, World Health Organization.
    Clin Calcium; 2007 Jul; 17(7):1106-13. PubMed ID: 17607079
    [Abstract] [Full Text] [Related]

  • 4. [Primary osteoporosis--its diagnosis and treatment].
    Inaba M.
    Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():485-9. PubMed ID: 18161153
    [No Abstract] [Full Text] [Related]

  • 5. [Up-to-date treatments for osteoporosis].
    Bors K.
    Orv Hetil; 2006 Feb 19; 147(7):301-6. PubMed ID: 17489157
    [Abstract] [Full Text] [Related]

  • 6. [Drug selection guide for osteoporosis determined by the clinical staging, pathophysiology and age].
    Tanaka I, Oshima H.
    Nihon Rinsho; 2009 May 19; 67(5):915-20. PubMed ID: 19432109
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic options in osteoporosis.
    Dominguez LJ, Scalisi R, Barbagallo M.
    Acta Biomed; 2010 May 19; 81 Suppl 1():55-65. PubMed ID: 20518192
    [Abstract] [Full Text] [Related]

  • 8. [Effects of SERMs on bone health. Effects of raloxifene and bisphosphonate on bone quality in osteoporosis: collagen cross-links, mineralization, and bone strength].
    Saito M.
    Clin Calcium; 2010 Mar 19; 20(3):345-54. PubMed ID: 20190364
    [Abstract] [Full Text] [Related]

  • 9. [Absolute risk for fracture and WHO guideline. Pharmacological intervention to prevent osteoporotic fractures in the elderly].
    Hosoi T, World Health Organization.
    Clin Calcium; 2007 Jul 19; 17(7):1098-104. PubMed ID: 17607078
    [Abstract] [Full Text] [Related]

  • 10. [Absolute risk for fracture and WHO guideline. Selection of drugs for the prevention of fractures in postmenopausal women].
    Gorai I, World Health Organization.
    Clin Calcium; 2007 Jul 19; 17(7):1090-6. PubMed ID: 17607077
    [Abstract] [Full Text] [Related]

  • 11. [Progress in the treatment of osteoporosis].
    Sugimoto T.
    Rinsho Byori; 2008 Oct 19; 56(10):887-93. PubMed ID: 19068785
    [Abstract] [Full Text] [Related]

  • 12. [Drug treatment for the treatment of primary osteoporosis].
    Halbekath J.
    Z Arztl Fortbild Qualitatssich; 2000 Aug 19; 94(6):453-60. PubMed ID: 10996934
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of osteoporosis].
    Lakatos P.
    Orv Hetil; 2003 Aug 03; 144(31):1551-2. PubMed ID: 14502870
    [No Abstract] [Full Text] [Related]

  • 14. Underdiagnosis and under-treatment of osteoporosis following fragility fracture.
    Aboyoussef M, Vierkoetter KR.
    Hawaii Med J; 2007 Jul 03; 66(7):185-7. PubMed ID: 17879856
    [Abstract] [Full Text] [Related]

  • 15. [Raloxifene and bone quality issues].
    Ohta H.
    Clin Calcium; 2005 Jun 03; 15(6):1012-9. PubMed ID: 15930716
    [Abstract] [Full Text] [Related]

  • 16. [Raloxifene in clinical practice. Results of the non-interventional study CORAL (COmpliance with RALoxifene)].
    Rosa J, Vanuga P, Payer J, Svobodník A.
    Vnitr Lek; 2008 Mar 03; 54(3):217-9, 221-4. PubMed ID: 18522288
    [Abstract] [Full Text] [Related]

  • 17. Pharmacotherapeutic management of osteoprosis and osteopenia.
    Alexander IM.
    Nurse Pract; 2009 Jun 03; 34(6):30-40; quiz 41. PubMed ID: 19474629
    [No Abstract] [Full Text] [Related]

  • 18. Selective estrogen receptor modulators: A possible new treatment of osteoporosis in males.
    Kastelan D, Giljevic Z, Kraljevic I, Korsic M.
    Med Hypotheses; 2006 Jun 03; 67(5):1052-3. PubMed ID: 16790322
    [Abstract] [Full Text] [Related]

  • 19. Pathophysiology and implications of cancer treatment-induced bone loss.
    Theriault RL.
    Oncology (Williston Park); 2004 May 03; 18(5 Suppl 3):11-5. PubMed ID: 15202582
    [Abstract] [Full Text] [Related]

  • 20. [Transplantation and osteoporosis].
    Tanaka Y.
    Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():531-6. PubMed ID: 18161161
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.